Angiotensin-converting enzyme (ACE) inhibitors a review of the comparative clinical and cost-effectiveness
This purpose of this report is to update a 2008 CADTH Rapid Response report on the comparative clinical and cost-effectiveness of angiotensin converting enzyme (ACE) inhibitors. In addition, it aims to examine the effectiveness of the combination of ACE inhibitors and diuretics compared to ACE inhib...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[Ottawa]
Canadian Agency for Drugs and Technologies in Health
12 June 2015, 2015
|
| Series: | Rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | This purpose of this report is to update a 2008 CADTH Rapid Response report on the comparative clinical and cost-effectiveness of angiotensin converting enzyme (ACE) inhibitors. In addition, it aims to examine the effectiveness of the combination of ACE inhibitors and diuretics compared to ACE inhibitors alone. The finding of this report can help produce clinical evidence as well as policy directions on the best and optimum use of individual ACE inhibitors for hypertension (HTN), heart failure (HF), myocardial infarction (MI), and diabetic nephropathy |
|---|---|
| Item Description: | Title from PDF caption title |
| Physical Description: | 1 PDF file (21 pages) illustrations |